Cargando…

Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies

Detalles Bibliográficos
Autores principales:	Spadafora, Luigi, Bernardi, Marco, Galli, Mattia, Biondi-Zoccai, Giuseppe, Sabouret, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710287/ https://www.ncbi.nlm.nih.gov/pubmed/36457983 http://dx.doi.org/10.5114/aoms/155411

Ejemplares similares

Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?
por: Bernardi, Marco, et al.
Publicado: (2023)

Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence
por: Cacciatore, Stefano, et al.
Publicado: (2023)

Coronary artery bypass grafting added to surgical aortic valve replacement in octogenarians
por: Spadafora, Luigi, et al.
Publicado: (2022)

Out-of-hospital cardiac arrest: predict and then protect!
por: Spadafora, Luigi, et al.
Publicado: (2023)

Feel Free to Use Aspirin before Coronary Artery Bypass Surgery
por: Ahn, Jung-Min
Publicado: (2019)

When early discharge after percutaneous coronary intervention is much too early
por: Siudak, Zbigniew, et al.
Publicado: (2022)

Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome
por: Björklund, Erik, et al.
Publicado: (2021)

Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity
por: Van Nguyen, Dinh, et al.
Publicado: (2012)

Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

The lack of aspirin resistance in patients with coronary artery disease
por: Homoródi, Nóra, et al.
Publicado: (2016)

Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test
por: O, Ibrahim, et al.
Publicado: (2013)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
por: Willemsen, Laura M., et al.
Publicado: (2021)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions
por: Perone, Francesco, et al.
Publicado: (2023)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Aspirin as Primary Prevention of Acute Coronary Heart Disease Events
por: Glasser, Stephen P., et al.
Publicado: (2014)

The association between aspirin resistance and extent and severity of coronary atherosclerosis
por: Kahraman, Serkan, et al.
Publicado: (2018)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
por: Ferrara, Pietro, et al.
Publicado: (2021)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

New approaches to reduce recurrent PCI: to angioplasty and beyond!
por: Sabouret, Pierre, et al.
Publicado: (2023)

Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper
por: Sabouret, Pierre, et al.
Publicado: (2022)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
por: Rawal, Shalin, et al.
Publicado: (2022)

Percutaneous coronary intervention in nonagenarians: pros and cons
por: Biondi Zoccai, Giuseppe, et al.
Publicado: (2013)

Elective percutaneous liver biopsy and use of aspirin
por: Reynard, Maxence Emmanuel, et al.
Publicado: (2022)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Guedeney, Paul, et al.
Publicado: (2020)

Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
por: Thakker, Ravi A., et al.
Publicado: (2022)

Factors related to on-treatment platelet aggregation assessed by multiple electrode aggregometry in percutaneous coronary intervention patients on clopidogrel and aspirin
por: Kukula, Krzysztof, et al.
Publicado: (2017)

Cost-Effectiveness of Clopidogrel vs Aspirin Monotherapy After Percutaneous Coronary Intervention: Results From the HOST-EXAM Study
por: Hwang, Doyeon, et al.
Publicado: (2023)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
por: Shi, Qiu-Ping, et al.
Publicado: (2022)

A systematic review and meta-analysis of percutaneous coronary intervention compared to coronary artery bypass grafting in non-ST-elevation acute coronary syndrome
por: Kirov, Hristo, et al.
Publicado: (2022)

Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
por: Dalmau, Maria J, et al.
Publicado: (2015)

Oral antiplatelet therapy in the elderly undergoing percutaneous coronary intervention: an umbrella review
por: Biondi-Zoccai, Giuseppe, et al.
Publicado: (2020)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease
por: Liu, Xian-Feng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ldogdbsr20ruefii74v9gg628k